| Novel antigenic targets of HPV therapeutic vaccines DR Boilesen, KN Nielsen, PJ Holst Vaccines 9 (11), 1262, 2021 | 31 | 2021 |
| Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication H Xu, AM Andersson, E Ragonnaud, D Boilesen, A Tolver, BAH Jensen, ... EBioMedicine 18, 204-215, 2017 | 16 | 2017 |
| The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus AS Jørgensen, EP Brandum, JM Mikkelsen, KA Orfin, DR Boilesen, ... Cellular and Molecular Life Sciences 78, 6963-6978, 2021 | 13 | 2021 |
| Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome–Positive C3 Cancers in Mice DR Boilesen, P Neckermann, T Willert, MD Müller, S Schrödel, C Pertl, ... Cancer Immunology Research 11 (2), 261-275, 2023 | 9 | 2023 |
| Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a … P Neckermann, DR Boilesen, T Willert, C Pertl, S Schrödel, C Thirion, ... Frontiers in Immunology 12, 761214, 2021 | 4 | 2021 |
| CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine γ-herpesvirus 68 infection DR Boilesen, E Ragonnaud, H Laursen, AMC Andersson, A Tolver, ... Vaccine 37 (22), 2952-2959, 2019 | 3 | 2019 |
| Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages P Neckermann, M Mohr, M Billmeier, A Karlas, DR Boilesen, C Thirion, ... Frontiers in Immunology 15, 1338492, 2024 | 1 | 2024 |
| Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors’ PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen J Daradoumis, MD Müller, P Neckermann, B Asbach, S Schrödel, ... Cancers 15 (24), 5863, 2023 | 1 | 2023 |
